ATS／ERS／JRS／ALAT临床实践指南：特发性肺纤维化的治疗(2015).pdf

AMERICAN THORACIC SOCIETY DOCUMENTS An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis An Update of the 2011 Clinical Practice Guideline Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A. Cuello Garcia, Arata Azuma, Juergen Behr, Jan L. Brozek, Harold R. Collard, William Cunningham*, Sakae Homma, Takeshi Johkoh, Fernando J. Martinez, Jeffrey Myers, Shandra L. Protzko, Luca Richeldi, David Rind, Moises´ Selman, Arthur Theodore, Athol U. Wells, Henk Hoogsteden, and Holger J. Schunemann;¨ on behalf of the ATS, ERS, JRS, and ALAT This guideline is dedicated to the memory of Mr. William Cunningham (June 7, 1935–October 23, 2014) THIS oFFICIAL CLINICAL PRACTICE GUIDELINE OF THE AMERICAN THORACIC SOCIETY (ATS) WAS APPROVED BY THE ATS, MAY 2015, THE EUROPEAN RESPIRATORY SOCIETY (ERS), APRIL 2015, THE JAPANESE RESPIRATORY SOCIETY (JRS), APRIL 2015, AND THE LATIN AMERICAN THORACIC ASSOCIATION (ALAT), APRIL 2015 Background: This document updates the American applied, and recommendations were formulated, written, and graded Thoracic Society/European Respiratory Society/ exclusively by the nonconflicted panelists. Japanese Respiratory Society/Latin American Thoracic Association guideline on idiopathic pulmonary fibrosis Results: After considering the confidence in effect estimates, the treatment. importance of outcomes studied, desirable and undesirable consequences of treatment, cost, feasibility, acceptability of the Methods: Systematic reviews and, when appropriate, meta-analyses intervention, and implications to health equity, recommendations were performed to summarize all available evidence pertinent to our were made for or against s